Must be signed in to post a comment.
Must be signed in to post a comment.
Wed Aug 20 2025
- views
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
Drug | Manufacturer |
---|---|
BELSOMRA (SUVOREXANT) | Merck Sharp & Dohme LLC |
51,320 cartons
Nationwide in the USA and PR.
Info not provided.
NDC |
---|
0006-0005-10 |
0006-0005-30 |
0006-0005-13 |
0006-0033-10 |
0006-0033-30 |
0006-0033-13 |
0006-0325-10 |
0006-0325-30 |
0006-0325-13 |
0006-0335-10 |
0006-0335-30 |
0006-0335-13 |
Wed Aug 20 2025
- views
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
Drug | Manufacturer |
---|---|
BELSOMRA (SUVOREXANT) | Merck Sharp & Dohme LLC |
51,320 cartons
Nationwide in the USA and PR.
Info not provided.
NDC |
---|
0006-0005-10 |
0006-0005-30 |
0006-0005-13 |
0006-0033-10 |
0006-0033-30 |
0006-0033-13 |
0006-0325-10 |
0006-0325-30 |
0006-0325-13 |
0006-0335-10 |
0006-0335-30 |
0006-0335-13 |
Wed Aug 20 2025
- views
Failed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the drug, delaying onset of sleep.
Drug | Manufacturer |
---|---|
BELSOMRA (SUVOREXANT) | Merck Sharp & Dohme LLC |
51,320 cartons
Nationwide in the USA and PR.
Info not provided.
NDC |
---|
0006-0005-10 |
0006-0005-30 |
0006-0005-13 |
0006-0033-10 |
0006-0033-30 |
0006-0033-13 |
0006-0325-10 |
0006-0325-30 |
0006-0325-13 |
0006-0335-10 |
0006-0335-30 |
0006-0335-13 |
0 views
0 views
0 views
Comments (-)
Must be signed in to post a comment.